119 online
 
Most Popular Choices
Share on Facebook 27 Printer Friendly Page More Sharing
Exclusive to OpEd News:
General News   

CANNED PFIZER CEO WALKS AWAY WITH $198 MILLION

By       (Page 1 of 1 pages)   No comments

Peter Rost
Newspapers were filled with information about Dr. McKinnell's $82 million pension package this spring.

Shareholders were upset that Dr. McKinnell would receive this amount considering that Pfizer's stock had lost almost 50% of its value during Dr. McKinnell's tenure.

Dr. McKinnell claimed that this wasn't his fault. He said that the stock had been overvalued when he took over. He didn't say that shareholders had been stupid, but in essence that is the conclusion.

Dr. McKinnell, however, has been anything but stupid. On December 18, 2006, Pfizer entered into an agreement with Dr. McKinnell which details the terms of his departure from Pfizer.

What Dr. McKinnell and Pfizer kept as their own little secret is that the $82 million retirement package wasn't all this CEO had coming his way. Dr. McKinnell got canned from his CEO job in July 2006, almost two years before he was scheduled to step down, under pressure from investors angered about his retirement package and lack of performance. Dr. McKinnell then "decided" to retire from his chairman job a few months early, on December 18, 2006, so Pfizer has now been forced to file an 8-K statement.

Turns out Dr. McKinnell had a few more dollars stashed away: $78 million in deferred pay to be exact, and $38 million in stock and severance payments.

So congratulations are appropriate. Not every CEO can set investors straight; cut the share price in half, and take off with $198 million in his knapsack. That takes a certain kind of talent.

According to the separation agreement, Dr. McKinnell agrees to "provide reasonable assistance to and cooperate with the Company and its counsel in regard to any litigation presently pending or subsequently initiated involving matters of which Executive has particular knowledge as a result of Executive's employment with the Company. Such assistance and cooperation shall consist of Executive making himself available at reasonable times for consultation with officers of the Company and its counsel and for depositions or other similar activity should the occasion arise."

That's good news for the many law firms that may be lining up to take Dr. McKinnell's deposition. After all, he might now have few excuses not to attend.
Rate It | View Ratings

Peter Rost Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

Peter Rost M.D. Peter Rost, M.D., is a former Vice President of Pfizer. He is the author of "The Whistleblower, Confessions of a Healthcare Hitman" and "Killer Drug." He also writes the daily Pharma Law Blog and the Pharma Expert Witness (more...)
 
Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Writers Guidelines

 
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEd News Newsletter
Name
Email
   (Opens new browser window)
 

Most Popular Articles by this Author:     (View All Most Popular Articles by this Author)

Anna Nicole Smith Autopsy: Abused Growth Hormone, Killed by Sleeping Aid.

Daniela Cicarelli's beach lover: Stud or dud?

Cannibalism in America: The placenta recipes.

The forbidden Daniela Cicarelli video.

The Michelle Manhart Video: U.S. Air Force Recruitment Tool?

The Michelle Manhart Affair: The US Air Force Listens!

To View Comments or Join the Conversation:

Tell A Friend